Advanced Molecular Detection: National investment to advance genomic sequencing capacity: California: November 11, 2022

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Total Investment1: $53,584,514
  
  State and Local Investment: $38,041,273
  
  Research Awards: $15,543,241
  
  Western Region
  
  CDC’s Advanced Molecular Detection (AMD) program builds and integrates laboratory, bioinformatics, and epidemiology
  
  technologies across CDC and nationwide. Since 2014, AMD has received support from Congress through an annual
  
  appropriation of $30 million—which was raised to $35 million in 2022—to implement these technologies in public health
  
  programs. Through investments in AMD technologies, CDC is improving both public health outcomes and preparedness in
  
  dozens of areas including foodborne disease, influenza, antibiotic resistance, hepatitis, pneumonia, and meningitis.
  
  CA-amd-investment-H.pdf
  
  
• Subjects:
  Communicable Diseases/diagnosis Disease Outbreaks/diagnosis Financing, Government Molecular Diagnostic Techniques Public Health Surveillance/methods
• Series:
  Advanced Molecular Detection National Investment
• Document Type:
  Text
• Name as Subject:
  Advanced Molecular Detection Initiative ; Advanced Molecular Detection Initiative
• Genre:
  Fact Sheet
• Place as Subject:
  California
• Pages in Document:
  2 unnumbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:29a2292a8d0e0f86ce5b9f1a5708f1f1045e6373f3655399fd76a716717f2b9e705e277e4aea8df4bdaec61def48323a79570c44931569d8daa4273bc8b5ae9f
• Download URL:
  https://stacks.cdc.gov/view/cdc/123493/cdc_123493_DS1.pdf
• File Type:
  [PDF - 996.44 KB ]